These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 27405061)

  • 41. Adjunctive therapy with vitamin c and thiamine in patients treated with steroids for refractory septic shock: A propensity matched before-after, case-control study.
    Coloretti I; Biagioni E; Venturelli S; Munari E; Tosi M; Roat E; Brugioni L; Gelmini R; Venturelli C; Girardis M
    J Crit Care; 2020 Oct; 59():37-41. PubMed ID: 32512351
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Global utilization of low-dose corticosteroids in severe sepsis and septic shock: a report from the PROGRESS registry.
    Beale R; Janes JM; Brunkhorst FM; Dobb G; Levy MM; Martin GS; Ramsay G; Silva E; Sprung CL; Vallet B; Vincent JL; Costigan TM; Leishman AG; Williams MD; Reinhart K
    Crit Care; 2010; 14(3):R102. PubMed ID: 20525247
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hemofiltration does not influence early S-100B serum levels in septic shock patients receiving stress doses of hydrocortisone or placebo.
    Mussack T; Briegel J; Schelling G; Jochum M
    Eur J Med Res; 2005 Feb; 10(2):81-7. PubMed ID: 15817428
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Double-Blind Randomized Clinical Trial Comparing Dopamine and Epinephrine in Pediatric Fluid-Refractory Hypotensive Septic Shock.
    Ramaswamy KN; Singhi S; Jayashree M; Bansal A; Nallasamy K
    Pediatr Crit Care Med; 2016 Nov; 17(11):e502-e512. PubMed ID: 27673385
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adrenal insufficiency in patients with cirrhosis and septic shock: Effect of treatment with hydrocortisone on survival.
    Fernández J; Escorsell A; Zabalza M; Felipe V; Navasa M; Mas A; Lacy AM; Ginès P; Arroyo V
    Hepatology; 2006 Nov; 44(5):1288-95. PubMed ID: 17058239
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Addition of vasopressin to norepinephrine as independent predictor of mortality in patients with refractory septic shock: an observational study.
    Micek ST; Shah P; Hollands JM; Shah RA; Shannon WD; Kollef MH
    Surg Infect (Larchmt); 2007 Apr; 8(2):189-200. PubMed ID: 17437364
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of Hydrocortisone on Regulating Inflammation, Hemodynamic Stability, and Preventing Shock in Severe Sepsis Patients.
    Zhao Y; Ding C
    Med Sci Monit; 2018 May; 24():3612-3619. PubMed ID: 29845974
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock.
    Russell JA; Walley KR; Gordon AC; Cooper DJ; Hébert PC; Singer J; Holmes CL; Mehta S; Granton JT; Storms MM; Cook DJ; Presneill JJ;
    Crit Care Med; 2009 Mar; 37(3):811-8. PubMed ID: 19237882
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of shock reversal with high or low dose hydrocortisone in intensive care unit patients with septic shock: A retrospective cohort study.
    Bonnin S; Radosevich JJ; Lee YG; Feldman JP; Barletta JF
    J Crit Care; 2021 Apr; 62():111-116. PubMed ID: 33338674
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vitamin C and Thiamine for Sepsis and Septic Shock.
    Mitchell AB; Ryan TE; Gillion AR; Wells LD; Muthiah MP
    Am J Med; 2020 May; 133(5):635-638. PubMed ID: 31469984
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Low-dose hydrocortisone reduces norepinephrine duration in severe burn patients: a randomized clinical trial.
    Venet F; Plassais J; Textoris J; Cazalis MA; Pachot A; Bertin-Maghit M; Magnin C; Rimmelé T; Monneret G; Tissot S
    Crit Care; 2015 Jan; 19(1):21. PubMed ID: 25619170
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical Outcomes of Minimized Hydrocortisone Dosage of 100 Mg/Day on Lower Occurrence of Hyperglycemia in Septic Shock Patients.
    Ngaosuwan K; Ounchokdee K; Chalermchai T
    Shock; 2018 Sep; 50(3):280-285. PubMed ID: 29176402
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characteristics of plasma NOx levels in severe sepsis: high interindividual variability and correlation with illness severity, but lack of correlation with cortisol levels.
    Ho JT; Chapman MJ; O'Connor S; Lam S; Edwards J; Ludbrook G; Lewis JG; Torpy DJ
    Clin Endocrinol (Oxf); 2010 Sep; 73(3):413-20. PubMed ID: 20455885
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [A meta-analysis to evaluate the effects of corticosteroids on the outcomes of patients with septic shock].
    Li Q; Xie JF; Liu L
    Zhonghua Nei Ke Za Zhi; 2020 Jun; 59(6):451-459. PubMed ID: 32486586
    [No Abstract]   [Full Text] [Related]  

  • 55. Corticosteroid therapy in refractory shock following cardiac arrest: a randomized, double-blind, placebo-controlled, trial.
    Donnino MW; Andersen LW; Berg KM; Chase M; Sherwin R; Smithline H; Carney E; Ngo L; Patel PV; Liu X; Cutlip D; Zimetbaum P; Cocchi MN;
    Crit Care; 2016 Apr; 20():82. PubMed ID: 27038920
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of thiamine on vasopressor requirements in patients with septic shock: a prospective randomized controlled trial.
    Petsakul S; Morakul S; Tangsujaritvijit V; Kunawut P; Singhatas P; Sanguanwit P
    BMC Anesthesiol; 2020 Nov; 20(1):280. PubMed ID: 33167911
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study.
    Keh D; Boehnke T; Weber-Cartens S; Schulz C; Ahlers O; Bercker S; Volk HD; Doecke WD; Falke KJ; Gerlach H
    Am J Respir Crit Care Med; 2003 Feb; 167(4):512-20. PubMed ID: 12426230
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Septic shock in intensive care units. Current focus on treatment].
    Arriagada S D; Donoso F A; Cruces R P; Díaz R F
    Rev Chil Pediatr; 2015; 86(4):224-35. PubMed ID: 26323988
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Controversies in Corticosteroid use for Sepsis.
    Long B; Koyfman A
    J Emerg Med; 2017 Nov; 53(5):653-661. PubMed ID: 28916121
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influence of vasopressor agent in septic shock mortality. Results from the Portuguese Community-Acquired Sepsis Study (SACiUCI study).
    Póvoa PR; Carneiro AH; Ribeiro OS; Pereira AC;
    Crit Care Med; 2009 Feb; 37(2):410-6. PubMed ID: 19114885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.